Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Audio Summaries
Every issue of Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology covers research in these specialties.
Recent summaries
The latest articles summarized from Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
Early Identification and Management of Otogenic and Nonotogenic Cerebral Venous Sinus Thrombosis
Jun 11, 2026
This study investigates the clinical differences between otogenic and nonotogenic cerebral venous sinus thrombosis (CVST) to enhance etiology-specific management strategies. The authors found that otogenic CVST is characterized by distinct clinical features and a higher treatment success rate compared to nonotogenic CVST, highlighting the importance of early differentiation for effective intervention. The study emphasizes the utility of D-dimer testing and magnetic resonance venography in diagnosing and managing these conditions.
Medical Therapy for NF2-related Schwannomatosis: A Systematic Review of Current Evidence
Jun 11, 2026
The authors aim to synthesize the existing evidence on medical therapies for managing NF2-related vestibular schwannomas. Their systematic review reveals that bevacizumab shows the most consistent efficacy in improving hearing and controlling tumors, while other therapies like mTOR inhibitors and tyrosine kinase inhibitors exhibit variable outcomes. The authors emphasize the need for high-quality, prospective randomized controlled trials to better understand the efficacy and comparative effectiveness of these treatments.
Efficacy of Vestibular Rehabilitation Therapy on Benign Paroxysmal Positional Vertigo After Repositioning: Improvement of Vestibular Symptoms and Vertigo Disability
Jun 10, 2026
The authors aimed to evaluate the efficacy of vestibular rehabilitation therapy (VRT) for patients with benign paroxysmal positional vertigo (BPPV) who continue to experience symptoms after repositioning, and to explore differences between the two subtypes of BPPV: posterior canal (pc-BPPV) and horizontal canal (hc-BPPV). The study found that VRT significantly improved residual symptoms compared to a control group, with subtype-specific differences observed in early symptom relief and functional recovery. These findings suggest that VRT can enhance rehabilitation outcomes for BPPV patients, highlighting the importance of tailored approaches based on BPPV subtype.